IP Library › Granted Patent US 12,521,510
Granted Patent B2
US 12,521,510 · App. 17/858,234 · Granted Jan 13, 2026

Mask vent

Inventors: Eva Ng (Sydney, AU); Robert Henry Frater (Sydney, AU); Lee James Veliss (Rotterdam, NL); Barton John Kenyon (Sydney, AU); Daniel Robert Judson (Blue Mountains, AU); Robert Edward Henry (Sydney, AU); Alison Oldenburg (Sydney, AU); Renee Frances Flower (Sydney, AU); Michael John Reid (Sydney, AU)
Assignee: ResMed Pty Ltd
A61M16/0666A61M16/0057A61M16/0066A61M16/009A61M16/06A61M16/08A61M16/0816A61M16/0875A61M16/1055A61M16/1065A61M16/208A61M2202/0085A61M2202/0225A61M2205/0205A61M2205/0238A61M2205/42
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,521,510
App. No.
17/858,234
Granted
Jan 13, 2026
Kind
B2
Abstract

A vent arrangement is provided to a mask or associated conduit to discharge exhaled gas from the mask to atmosphere. The vent arrangement is structured to diffuse the exhaust vent flow to produce less air jetting, thereby increasing the comfort of the patient and their bed partner. For example, the vent arrangement may include one or more grill components and/or media constructed and arranged to diffuse vent flow.

Claims (18)

1 . A patient interface for treatment of sleep related breathing disorders, the patient interface comprising:

a patient contacting portion configured to form a seal with a patient's nose and/or mouth;

an interior portion configured to provide fluid communication with the patient's nose and/or mouth;

a connection configured to connect with an air delivery conduit and provide pressurized breathing gas to the patient via the interior portion; and

a vent configured to discharge an exhaled gas from the interior portion to atmosphere, wherein the vent comprises:

a base including a plurality of adjacent openings in fluid communication with the interior portion,

a media spaced away from the plurality of adjacent openings and configured such that the exhaled gas being discharged from the plurality of adjacent openings flows toward the media,

wherein the base includes a support configured to support the media at a distance away from the plurality of adjacent openings, and

a cover configured to maintain the media within the base,

wherein the base includes an annular side wall configured to engage the cover, and the annular side wall extends upwardly relative to the support such that the support is recessed within the base relative to the annular side wall.

2 . The patient interface according to claim 1 , wherein the media is a filter, a membrane, a fabric, a mesh, or another porous material.

3 . The patient interface according to claim 1 , wherein the plurality of adjacent openings is within a first area and the media has perimeter edges that extend beyond the first area.

4 . The patient interface according to claim 1 , wherein the media is configured to diffuse the exhaled gas discharged through the vent.

5 . The patient interface according to claim 1 , wherein the plurality of adjacent openings is configured to diffuse the exhaled gas discharged through the vent.

6 . The patient interface according to claim 1 , wherein the gas being discharged from the plurality of adjacent openings flows through the media.

7 . The patient interface according to claim 1 , wherein the media is configured to prevent clogging of the plurality of adjacent openings.

8 . The patient interface according to claim 1 , further comprising at least one lateral opening configured so that at least a portion of the exhaled gas is released to the surrounding atmosphere.

9 . The patient interface according to claim 1 , wherein the vent is a removable component of the patient interface.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 6, 2022
From: NG, EVA; OLDENBURG, ALISON; VELISS, LEE JAMES; HENRY, ROBERT EDWARD; FLOWER (FORMERLY RENEE FRANCES DOHERTY), RENEE FRANCES; FRATER, ROBERT HENRY; KENYON, BARTON JOHN; JUDSON, DANIEL ROBERT; REID, MICHAEL JOHN
To: RESMED LIMITED
Reel/Frame 060409/0059 →
CHANGE OF REGISTERED NAME AND ADDRESS Recorded Jul 6, 2022
From: RESMED LIMITED
To: RESMED PTY LTD
Reel/Frame 060590/0333 →
Continuity (9)
Continuation 16735876 · Jan 7, 2020
Continuation 15837100 · Dec 11, 2017
Continuation 14475941 · Sep 3, 2014
Continuation 13773846 · Feb 22, 2013
Continuation 12230120 · Aug 22, 2008
Provisional Application 61129253 · Jun 13, 2008
Provisional Application 61064405 · Mar 4, 2008
Provisional Application 60957766 · Aug 24, 2007
Related Publication 20220339387A1 · Oct 27, 2022
References Cited (120)
US 2241535A · Boothby · 1941 [cited by applicant]
US 2944547A · Ziherl et al. · 1960 [cited by applicant]
US 4501271A · Clifton et al. · 1985 [cited by applicant]
US 4784129A · Garrafa · 1988 [cited by applicant]
US 4919128A · Kopala · 1990 [cited by applicant]
US 4981134A · Courtney · 1991 [cited by applicant]
US 4989596A · Macris et al. · 1991 [cited by applicant]
US 5103817A · Reisdorf · 1992 [cited by applicant]
US 5117821A · White · 1992 [cited by applicant]
US 5269296A · Landis · 1993 [cited by applicant]
US 5372130A · Stern et al. · 1994 [cited by applicant]
US 5438981A · Starr et al. · 1995 [cited by applicant]
US 5558466A · Kuo et al. · 1996 [cited by applicant]
US 5560354A · Berthon-Jones et al. · 1996 [cited by applicant]
US 5647357A · Barnett et al. · 1997 [cited by applicant]
US 5657752A · Landis et al. · 1997 [cited by applicant]
US 5662101A · Ogden et al. · 1997 [cited by applicant]
US D387734S · Hawkins et al. · 1997 [cited by applicant]
US 5746201A · Kidd · 1998 [cited by applicant]
US 5896857A · Hely et al. · 1999 [cited by applicant]
US 5937851A · Serowski et al. · 1999 [cited by applicant]
US 6123071A · Berthon-Jones et al. · 2000 [cited by applicant]
US 6125849A · Williams et al. · 2000 [cited by applicant]
US 6341606B1 · Bordewick · 2002 [cited by applicant]
US 6460539B1 · Japuntich et al. · 2002 [cited by applicant]
US 6561190B1 · Kwok et al. · 2003 [cited by applicant]
US 6581594B1 · Drew et al. · 2003 [cited by applicant]
US 6584977B1 · Serowski · 2003 [cited by applicant]
US 6659102B1 · Sico · 2003 [cited by examiner]
US 6662803B2 · Gradon et al. · 2003 [cited by applicant]
US 6691707B1 · Gunaratnam et al. · 2004 [cited by applicant]
US 6851425B2 · Jaffre et al. · 2005 [cited by applicant]
US 6907882B2 · Ging et al. · 2005 [cited by applicant]
US 7066178B2 · Gunaratnam et al. · 2006 [cited by applicant]
US D535023S · Smart et al. · 2007 [cited by applicant]
US 7267120B2 · Rustad et al. · 2007 [cited by applicant]
US 7302950B2 · Berthon-Jones et al. · 2007 [cited by applicant]
US 7316230B2 · Drew · 2008 [cited by applicant]
US 7341060B2 · Ging · 2008 [cited by applicant]
US D580048S · Guney et al. · 2008 [cited by applicant]
US D594113S · Reid et al. · 2009 [cited by applicant]
US D612481S · Reid et al. · 2010 [cited by applicant]
US 7836886B2 · McDonald et al. · 2010 [cited by applicant]
US 7861713B2 · Dhuper et al. · 2011 [cited by applicant]
US 7913692B2 · Kwok · 2011 [cited by applicant]
US 8397727B2 · Ng et al. · 2013 [cited by applicant]
US 8439035B2 · Dantanarayana et al. · 2013 [cited by applicant]
US 8678003B2 · Darkin et al. · 2014 [cited by applicant]
US 8851075B2 · Ng et al. · 2014 [cited by applicant]
US 10543333B2 · Ng et al. · 2020 [cited by applicant]
US 20020014241A1 · Gradon · 2002 [cited by examiner]
US 20030005931A1 · Jaffre et al. · 2003 [cited by applicant]
US 20030079751A1 · Kwok et al. · 2003 [cited by applicant]
US 20040025881A1 · Gunaratnam · 2004 [cited by applicant]
US 20040094157A1 · Dantanarayana et al. · 2004 [cited by applicant]
US 20040103899A1 · Noble · 2004 [cited by applicant]
US 20040226566A1 · Gunaratnam · 2004 [cited by applicant]
US 20050205096A1 · Matula, Jr. · 2005 [cited by applicant]
US 20060266365A1 · Stallard · 2006 [cited by applicant]
US 20070062536A1 · McAuley et al. · 2007 [cited by applicant]
US 20070101990A1 · Hacke · 2007 [cited by examiner]
US 20070113854A1 · Mcauliffe · 2007 [cited by examiner]
US 20090050156A1 · Ng et al. · 2009 [cited by applicant]
US 20110061655A1 · McDonald et al. · 2011 [cited by applicant]
US 20110120457A1 · Dhuper et al. · 2011 [cited by applicant]
US 20110180071A1 · Veliss et al. · 2011 [cited by applicant]
US 20130160769A1 · Ng et al. · 2013 [cited by applicant]
US 20140366882A1 · Ng et al. · 2014 [cited by applicant]
US 20170291004A1 · Ng et al. · 2017 [cited by applicant]
US 20180104431A1 · Ng et al. · 2018 [cited by applicant]
US 20200306479A1 · Ng et al. · 2020 [cited by applicant]
DE 10331134 · 2005 [cited by applicant]
EP 0697225 · 1996 [cited by applicant]
EP 0958841 · 1999 [cited by applicant]
JP 2004535226 · 2004 [cited by applicant]
JP 2005537905 · 2005 [cited by applicant]
JP 200950707 · 2009 [cited by applicant]
WO WO9834665 · 1998 [cited by applicant]
WO WO199834665 · 1998 [cited by applicant]
WO WO9848879 · 1998 [cited by applicant]
WO WO0078382 · 2000 [cited by applicant]
WO WO2002051486 · 2002 [cited by applicant]
WO WO2002096342 · 2002 [cited by applicant]
WO 2005051468A1 · 2005 [cited by applicant]
WO WO2005051468 · 2005 [cited by applicant]
WO WO2006024288 · 2006 [cited by applicant]
WO WO2006069415 · 2006 [cited by applicant]
WO WO2006074516 · 2006 [cited by applicant]
WO WO2006096924 · 2006 [cited by applicant]
WO WO2006122369 · 2006 [cited by applicant]
WO WO2007012140 · 2007 [cited by applicant]
WO WO2007012145 · 2007 [cited by applicant]
First Examination Report dated Oct. 24, 2017 issued in New Zealand Application No. 735401 (3 pages). [cited by applicant]
First Office Action issued in corresponding Japanese Application No. 2014-160191 dated Aug. 24, 2015, with English translation thereof. [cited by applicant]
Communication pursuant to Article 94(3) EPC issued in corresponding European Application No. 11 181 712.8 dated April 26, 2016. [cited by applicant]
Second Office Action issued in corresponding Japanese Application No. 2014-160191 dated April 18, 2016 with English translation thereof. [cited by applicant]
Further Examination Report issued in corresponding New Zealand Patent Application No. 718484 dated Jul. 5, 2016. [cited by applicant]
Statement of Case dated Oct. 28, 2016 filed in New Zealand Application No. 701093 (11 pages). [cited by applicant]
Office Action dated Dec. 21, 2016 issued in European Application No. 111817128 (4 pages). [cited by applicant]
Office Action dated Dec. 19, 2016 issued in Japanese Application No. 2014-160191 with English translation (5 pages). [cited by applicant]
Extension of Time Granted dated Aug. 31, 2016, together with a Notice of Opposition to Grant of Patent (Section 21) filed on Aug. 29, 2016 by Fisher & Paykel Healthcare Limited in correspbhding New Zealand Application N… [cited by applicant]
U.S. Appl. No. 10/585,091 (2007/0267023), filed Dec. 2004 (Nov. 2007), Ging et al. [cited by applicant]
U.S. Appl. No. 11/027,689 (2005/0172969), filed Jan. 2005 (Aug. 2005), Ging et al. [cited by applicant]
U.S. Appl. No. 11/878,932 (2008/0060649), filed Jul. 2007 (Mar. 2008), Veliss et al. [cited by applicant]
U.S. Appl. No. 11/878,933 (2008/0047560), filed Jul. 2007 (Feb. 2008), Veliss et al. [cited by applicant]
U.S. Appl. No. 11/952,167 (2008-0087287), filed Dec. 2007 (Apr. 2008), Ging et al. [cited by applicant]
U.S. Appl. No. 60/924,359, filed May 2007, Davidson et al. [cited by applicant]
European Search Report, Appln. No. 08162863, dated Nov. 17, 2008, 7 pages. [cited by applicant]
Extended European Search Report issued in EP Appln. No. 11181712.8 dated Jan. 24, 2012. [cited by applicant]
Chinese Office Action issued in related Application No. 200810210534.1 dated Mar. 15, 2012. [cited by applicant]
Office Action issued in a corresponding Japanese Application No. 2008-215721 dated Dec. 21, 2012, with English translation thereof. [cited by applicant]
Further Examination Report issued in corresponding New Zealand Appln. No. 599608 dated Mar. 13, 2013. [cited by applicant]
First Examination Report issued in corresponding New Zealand Appln. No. 610424 dated May 16, 2013. [cited by applicant]
Further Examination Report issued in corresponding New Zealand Appln. No. 599608 dated Aug. 22, 2013. [cited by applicant]
Notice of Reasons for Rejection issued in corresponding Japanese Appln. No. 2013-058108 dated Feb. 17, 2014, with English translation thereof. [cited by applicant]
Office Action dated Aug. 8, 2018 issued in U.S. Appl. No. 15/628,852 with Form PTO-892 citing U.S. Pat. No. 2,241,535 A, U.S. Pat. No. 4,919,128 A, U.S. Pat. No. 6,341,606 B1, US 2004/0226566 A1, and U.S. Pat. No. 8,485… [cited by applicant]
Amended Statement of Case (Clean and Track Changes), filed by Fisher & Paykel Healthcare Limited on Feb. 7, 2019 in New Zealand Application No. 701093, 28 pages. [cited by applicant]
Ng et al., U.S. Appl. No. 15/837,100, filed Dec. 11, 2017, entitled “Mask Vent,” specification, claims and drawings (parent application). [cited by applicant]
Office Action dated Apr. 5, 2018 issued in U.S. Appl. No. 16/735,876, filed Jan. 7, 2020 (35 pages) NG et al., U.S. Appl. No. 16/735,876, filed Jan. 7, 2020, for “Mask Vent,” (parent application). [cited by applicant]
Ng et al., U.S. Appl. No. 16/735,876, filed Jan. 7, 2020, for “Mask Vent,” (parent application). [cited by applicant]